用于癌症成像与治疗的放射性药物。
Radiopharmaceuticals for Cancer Imaging and Therapy.
作者信息
Bormans Guy, Cleeren Frederik
机构信息
Laboratory for Radiopharmaceutical Research, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium.
出版信息
Pharmaceutics. 2023 Aug 31;15(9):2262. doi: 10.3390/pharmaceutics15092262.
Abstract
Nuclear medicine has emerged as a pivotal player in cancer patient care, revolutionizing the way cancer is detected, diagnosed, monitored, and treated [...].
摘要
核医学已成为癌症患者护理中的关键角色，彻底改变了癌症的检测、诊断、监测和治疗方式[……]。
相似文献
1
Radiopharmaceuticals for Cancer Imaging and Therapy.用于癌症成像与治疗的放射性药物。
Pharmaceutics. 2023 Aug 31;15(9):2262. doi: 10.3390/pharmaceutics15092262.
2
Nuclear medicine procedures in lung cancer.肺癌的核医学检查程序
Eur J Nucl Med. 1999 May;26(5):533-55. doi: 10.1007/s002590050422.
3
The current role of nuclear medicine in breast cancer.核医学在乳腺癌中的当前作用。
Br J Radiol. 2023 Sep;96(1149):20221153. doi: 10.1259/bjr.20221153. Epub 2023 Apr 26.
4
The bright future of radionuclides for cancer therapy.放射性核素用于癌症治疗的光明前景。
Anticancer Agents Med Chem. 2007 May;7(3):271-90. doi: 10.2174/187152007780618207.
5
Radiopharmaceuticals in the elderly cancer patient: Practical considerations, with a focus on prostate cancer therapy: A position paper from the International Society of Geriatric Oncology Task Force.老年癌症患者的放射性药物：实际考量，重点关注前列腺癌治疗：国际老年肿瘤学会特别工作组的立场文件
Eur J Cancer. 2017 May;77:127-139. doi: 10.1016/j.ejca.2017.01.030. Epub 2017 Apr 7.
6
Radiopharmaceuticals for the Diagnosis and Therapy of Neuroendocrine Differentiated Prostate Cancer.用于神经内分泌分化型前列腺癌诊断与治疗的放射性药物
Curr Radiopharm. 2017;10(1):6-15. doi: 10.2174/1874471009666161229123126.
7
Global Issues of Radiopharmaceutical Access and Availability: A Nuclear Medicine Global Initiative Project.全球放射性药物可及性和可获取性问题：核医学全球倡议项目。
J Nucl Med. 2021 Mar;62(3):422-430. doi: 10.2967/jnumed.120.247197. Epub 2020 Jul 9.
8
Economics of New Molecular Targeted Personalized Radiopharmaceuticals.新型分子靶向个体化放射性药物的经济学评价
Semin Nucl Med. 2019 Sep;49(5):450-457. doi: 10.1053/j.semnuclmed.2019.07.002.
9
Updated Review of Nuclear Molecular Imaging of Thyroid Cancers.甲状腺癌核分子影像的最新综述
Endocr Pract. 2021 May;27(5):494-502. doi: 10.1016/j.eprac.2020.10.001. Epub 2020 Dec 14.
10
Aptamers as radiopharmaceuticals for nuclear imaging and therapy.适配体作为用于核成像和治疗的放射性药物。
Nucl Med Biol. 2016 Apr;43(4):253-71. doi: 10.1016/j.nucmedbio.2015.09.005. Epub 2015 Sep 28.
引用本文的文献
1
Development of a Novel, Easy-to-Prepare, and Potentially Valuable Peptide Coupling Technology Utilizing Amide Acid as a Linker.利用酰胺酸作为连接体开发一种新型、易于制备且具有潜在价值的肽偶联技术。
Pharmaceuticals (Basel). 2024 Jul 24;17(8):981. doi: 10.3390/ph17080981.
本文引用的文献
1
Effect of -Terminal Peptide Modifications on In Vitro and In Vivo Properties of Lu-Labeled Peptide Analogs Targeting CCK2R.C末端肽修饰对靶向CCK2R的镥标记肽类似物体外和体内性质的影响。
Pharmaceutics. 2023 Feb 28;15(3):796. doi: 10.3390/pharmaceutics15030796.
2
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [Sm]Sm-DOTA-TATE.探索高摩尔活度钐-153通过[钐]钐-多胺多羧基大环配体-酪胺酸的靶向放射性核素治疗潜力。
Pharmaceutics. 2022 Nov 23;14(12):2566. doi: 10.3390/pharmaceutics14122566.
3
A Review on Tumor Control Probability (TCP) and Preclinical Dosimetry in Targeted Radionuclide Therapy (TRT).靶向放射性核素治疗（TRT）中的肿瘤控制概率（TCP）与临床前剂量测定综述
Pharmaceutics. 2022 Sep 22;14(10):2007. doi: 10.3390/pharmaceutics14102007.
4
Simultaneous Imaging and Therapy Using Epitope-Specific Anti-Epidermal Growth Factor Receptor (EGFR) Antibody Conjugates.使用表位特异性抗表皮生长因子受体（EGFR）抗体偶联物进行同步成像与治疗
Pharmaceutics. 2022 Sep 10;14(9):1917. doi: 10.3390/pharmaceutics14091917.
5
Evaluation of an Affibody-Based Binder for Imaging of Immune Check-Point Molecule B7-H3.一种基于亲和体的免疫检查点分子B7-H3成像结合物的评估
Pharmaceutics. 2022 Aug 25;14(9):1780. doi: 10.3390/pharmaceutics14091780.
6
Preclinical Evaluation of a New Format of Ga- and In-Labeled Affibody Molecule Z for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT.新型镓和铟标记的亲和体分子Z用于正电子发射断层扫描（PET）和单光子发射计算机断层扫描（SPECT）可视化恶性肿瘤中胰岛素样生长因子-1受体（IGF-1R）表达的临床前评估
Pharmaceutics. 2022 Jul 15;14(7):1475. doi: 10.3390/pharmaceutics14071475.
7
Experimental Therapy of HER2-Expressing Xenografts Using the Second-Generation HER2-Targeting Affibody Molecule Re-ZHER2:41071.使用第二代HER2靶向亲和体分子Re-ZHER2:41071对HER2表达异种移植瘤进行实验性治疗
Pharmaceutics. 2022 May 20;14(5):1092. doi: 10.3390/pharmaceutics14051092.
8
Improved Characteristics of RANKL Immuno-PET Imaging Using Radiolabeled Antibody Fab Fragments.使用放射性标记抗体Fab片段改善RANKL免疫PET成像的特性
Pharmaceutics. 2022 Apr 26;14(5):939. doi: 10.3390/pharmaceutics14050939.
Zotero 插件